Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108084129B details a novel enantioselective Baeyer-Villiger oxidation for prostaglandin intermediates, offering high ee values and scalable manufacturing solutions.
Novel 2-step synthesis of Montelukast intermediate via Wittig and Pd-coupling. Reduces cost and steps for API manufacturing.
Patent CN116003211B reveals novel Suzuki coupling. Offers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing.
Novel copper-catalyzed radical coupling method for chiral 3-aminopiperidine. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Novel hydrogenation process reduces noble metal usage and improves purity for sitagliptin manufacturing, offering significant cost and supply chain advantages.
Patent CN105503737A describes catalyst-free benzimidazole synthesis in water. This green method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis method for bis(hydroxyethylaminopropyl)hydroxyethyl oleylamine via patent CN119191996A. Offers high purity and scalable production for global supply chains.
Novel quinine-based resolution method for (S)-oxiracetam ensures high optical purity and scalable production for pharmaceutical supply chains.
Novel micro-reactor process ensures high purity and safety for pharmaceutical intermediates. Reduces toxic reagents and enhances supply chain reliability significantly.
Novel phytic acid metal complex catalyst enables sustainable synthesis of benzoxazole derivatives with improved supply chain reliability and cost efficiency.
Patent CN113999214B reveals a novel Rh-catalyzed route for indole dihydrofuran derivatives, offering high stereoselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110003299A details a novel THF-based synthesis for Betamethasone intermediates offering higher purity and reduced toxicity for reliable pharmaceutical supply chains.
Patent CN103408573A reveals a novel NHC-catalyzed borylation method for high-purity boronic acid derivatives, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Novel metal-free synthesis of polyfluoroalkyl cyclobutene derivatives. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Discover a novel preparation method for Levalbuterol Hydrochloride via asymmetric reduction. Achieve high purity without column chromatography for cost-effective API manufacturing.
Novel organoiodine catalysis method for high-purity benzomorpholinone intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN116751196B introduces Rh660 catalyst for N-benzyltropine. Enhances yield and safety. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN105568312B reveals metal-free electrocatalytic route for high-purity pharmaceutical intermediates, offering substantial cost reduction and supply chain reliability.
Discover CN101983186B technology for asymmetric hydrogenation. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.